Thanatsaran Saenlom

3PUBLICATIONS
6CO-AUTHORS
Tumour immunologyGlycoconjugatesBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Dec 23, 2023
Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer.

Kodchakorn Mahasongkram, Kantaphon Glab-Ampai, Kanasap Kaewchim

|Oct 28, 2023
Correction: Kaewchim et al. Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. Viruses 2023, 15, 1252.

Kanasap Kaewchim, Kittirat Glab-Ampai, Kodchakorn Mahasongkram

|Jun 28, 2023
Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies.

Kanasap Kaewchim, Kittirat Glab-Ampai, Kodchakorn Mahasongkram

Pageof 1

Frequent Collaborators

3 joint publications

Kanasap Kaewchim

3 joint publications

Kittirat Glab-Ampai

3 joint publications

Monrat Chulanetra

3 joint publications

Wanpen Chaicumpa

2 joint publications

Kiattawee Choowongkomon

1 joint publications

Kodchakorn Mahasongkram

Frequent Collaborators

3 joint publications

Kanasap Kaewchim

3 joint publications

Kittirat Glab-Ampai

3 joint publications

Monrat Chulanetra

3 joint publications

Wanpen Chaicumpa

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.6K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance
13:00

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance

Published on : Jun 14, 2022

2.4K
See more related videos

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.6K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance
13:00

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance

Published on : Jun 14, 2022

2.4K
See more related videos